SEOM clinical guidelines for the treatment of thyroid cancer

SEOM clinical guidelines for the treatment of thyroid cancer,10.1007/s12094-011-0700-3,Clinical & Translational Oncology,Javier Martínez Trufero,Jaume

SEOM clinical guidelines for the treatment of thyroid cancer  
BibTex | RIS | RefWorks Download
Although thyroid cancer represents less than 1% of malignant tumours, its increased incidence detected in recent years and the appearance and development of new drugs targeting specific molecular targets has attracted the attention of the doctors involved in this pathology, especially medical oncologists. For this reason it is important at this critical point, when treatment may be substantially changed, to establish and agree updated guidelines. These guidelines should incorporate the newly developed strategies that, although still preliminary in evidence level, will surely have an important role, especially in relapsed and refractory tumours, which are unsuitable for surgical or radio-iodine treatment. Particular histological and molecular features of these tumours must be taken into account in order to optimise therapeutic approaches.
Journal: Clinical & Translational Oncology - CLIN TRANSL ONCOL , vol. 13, no. 8, pp. 574-579, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.